Article Correctness Is Author's Responsibility: Stroke clot-buster drugs could be harnessed to tackle COVID-19

The article below may contain offensive and/or incorrect content.

This shows covid19An aerosolized version of tissue plasminogen activator (tPA), a clot-busing drug commonly used for the treatment of stroke patients, could target blood clots that form as a result of severe coronavirus infection.